Maravai LifeSciences is a brand that is dedicated to enabling the miracles of science. They offer a portfolio of market-leading companies and proprietary technologies that support the development of drug therapies, diagnostics, and novel vaccines. Maravai understands the importance of biomedical innovation and the need for reliable reagents in the fields of nucleic acid production and biologics safety testing.

Their customers range from inventive startups to some of the world's leading biopharma, vaccine, diagnostics, and cell and gene therapy companies. They rely on Maravai to help them address complex discovery challenges and streamline their processes from research to commercialization. Their portfolio includes TriLink BioTechnologies, a global leader in RNA synthesis and scale-up, Glen Research, a leader in specialty reagents for DNA and RNA synthesis, Cygnus Technologies, a pioneer in bioprocess impurity detection, and Alphazyme, a manufacturer of molecular biology enzymes.

With a number of patents and innovative products and services, Maravai is at the forefront of advancing scientific research and improving human well-being